Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fujifilm Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0502
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofinishing, functional materials, graphic systems, recording media, electronic materials and industrial products, and office printers. The company offers its services to individual consumers and business enterprises. Fujifilm conducts its business operations through its subsidiaries across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Fujifilm Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fujifilm Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Fujifilm and Takeda Pharma Enter into Agreement 12
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 13
EdiGene Enters into Research Agreement with Fujifilm 14
CanBas Enters into Research Agreement with Fujifilm 15
FunPep Enters into Research Agreement with Fujifilm 16
China Resources Pharmaceutical Enters into Agreement with Fujifilm 17
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 18
Bioaster Partners with Fujifilm 19
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 20
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 21
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 22
Licensing Agreements 23
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 23
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 24
Equity Offering 25
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 25
Fujifilm Invests USD0.3 Million in Japan Biomedical 26
Fujifilm Invests USD1.5 Million in Regcell 27
Acquisition 28
Fujifilm Acquires 11.7% Stake in EdiGene 28
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 29
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 30
Fujifilm Corp – Key Competitors 31
Fujifilm Corp – Key Employees 32
Fujifilm Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Feb 28, 2017: Expanding Fast-Growing Contract Development and Manufacturing Business for Biopharmaceuticals, FUJIFILM Launches the Bio CDMO Division 37
Other Significant Developments 38
Nov 06, 2017: Fujifilm Expands Biopharmaceutical Contract Development and Manufacturing Business, Increasing Monoclonal Antibody Capacity for Process Development and GMP Production at U.S.A. and U.K. Sites 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Fujifilm Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fujifilm and Takeda Pharma Enter into Agreement 12
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 13
EdiGene Enters into Research Agreement with Fujifilm 14
CanBas Enters into Research Agreement with Fujifilm 15
FunPep Enters into Research Agreement with Fujifilm 16
China Resources Pharmaceutical Enters into Agreement with Fujifilm 17
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 18
Bioaster Partners with Fujifilm 19
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 20
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 21
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 22
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 23
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 24
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 25
Fujifilm Invests USD0.3 Million in Japan Biomedical 26
Fujifilm Invests USD1.5 Million in Regcell 27
Fujifilm Acquires 11.7% Stake in EdiGene 28
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 29
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 30
Fujifilm Corp, Key Competitors 31
Fujifilm Corp, Key Employees 32
Fujifilm Corp, Other Locations 33
Fujifilm Corp, Subsidiaries 34
Fujifilm Corp, Joint Venture 36

List of Figures
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fujifilm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fujifilm Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinopac Financial Holdings Company Limited
    Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Noramco Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The company's products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, …
  • Colorado Farm Bureau Mutual Insurance Co.:企業の戦略・SWOT・財務情報
    Colorado Farm Bureau Mutual Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary Colorado Farm Bureau Mutual Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Cathedral Energy Services Ltd (CET):企業の財務・戦略的SWOT分析
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, production testing services, measurement while drilling services a …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BioLight Israeli Life Sciences Ltd (BOLT)-医療機器分野:企業M&A・提携分析
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light), Bio Light Israeli Life Sciences Investments Ltd is an ophthalmic company that discovers, develops and commercializes products and product candidates for various ophthalmic conditions. The company invests in managing and commercializing biomedic …
  • Stanmore Coal Ltd:企業の戦略・SWOT・財務分析
    Stanmore Coal Ltd - Strategy, SWOT and Corporate Finance Report Summary Stanmore Coal Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Banco Santander SA:戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Spaulding Clinical Research LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Spaulding Clinical Research LLC (Spaulding Clinical Research) is a CRO providing Phase I - IV drug development services to biotechnologyand pharmaceutical companies. The company provides spaulding electrocardiograph and spauldingwebECG. It provides data management services which such as eCRF …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tieto Corp (TIETO):企業の財務・戦略的SWOT分析
    Tieto Corp (TIETO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SensoDetect AB:医療機器:M&Aディール及び事業提携情報
    Summary SensoDetect AB (SensoDetect) is a medical device company that provides diagnostic products. The company develops neuro physiological decision support systems for diagnostics in psychiatric health care and forensics. Its SensoDetect BERA is a test instrument based on brainstem audiometry whic …
  • Qc Holdings Inc:企業の戦略・SWOT・財務分析
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pedernales Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Pedernales Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Diplomat Pharmacy Inc (DPLO):企業の財務・戦略的SWOT分析
    Diplomat Pharmacy Inc (DPLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Electricity Authority of Cyprus:企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Al Rajhi Banking & Investment Corporation (1120):企業の財務・戦略的SWOT分析
    Al Rajhi Banking & Investment Corporation (1120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • The Chemours Company, LLC:戦略・SWOT・企業財務分析
    The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆